Top Regulated Brokers
Short Trade Idea
Enter your short position between $110.75 (an intermediate horizontal support level) and $113.68 (yesterday’s intra-day high).
Market Index Analysis
Merck & Co (NYSE:MRK) is a member of the Dow Jones Industrial Average Index, the S&P 100 Index, and the S&P 500 Index.
All three indices push higher, recording all-time highs, driven entirely by optimism over AI hyperscaler capex following an encouraging tech earnings season.
The Bull Bear Power Indicator for the S&P 500 Index is bullish with a negative divergence.
Market Sentiment Analysis
Equity futures are slightly lower this morning after another record-setting move yesterday, as markets brace for April’s CPI report. Expectations call for a 3.7% rise, but any reaction to the release could be temporary, as markets are solely focused on AI and semiconductors, fueling parabolic increases that could extend today after earnings from Applied Materials, Cisco Systems, and Alibaba Group.
Merck & Co Fundamental Analysis
Merck & Co is a multinational pharmaceutical company. It is a leader in cancer treatments, with vaccines and animal health products rounding out its top three revenue drivers.
So, why am I bearish on MRK following its post-earnings bump?
While Merck & Co reported revenues of $16.29 billion and earnings per share of -$1.28, ahead of expectations of $15.85 billion and -$1.47, I remain bearish, driven by three significant Phase 3 oncology trials that failed (LITESPARK-012, KEYNOTE-975, and KEYNOTE-866). The 2028 patent expiration for Keytruda, which accounts for over 50% of total sales, and the collapsing GARDASIL sales add to an uncertain future with immense revenue concentration, while generic competition intensifies pricing pressures.
MMRKic | Value | Verdict |
P/E Ratio | 31.35 | Bearish |
P/B Ratio | 6.00 | Bearish |
PEG Ratio | 5.18 | Bearish |
Current Ratio | 1.30 | Bearish |
ROIC-WACC Ratio | Positive | Bullish |
Merck & Co Fundamental Analysis Snapshot
The price-to-earning (P/E) ratio of 31.35 makes MRK an expensive stock. By comparison, the P/E ratio for the S&P 500 Index is 31.91.
The average analyst price target for MRK is $129.74. This suggests good upside potential, but downside risks remain high.
Merck & Co Technical Analysis
Today’s MRK Signal
The MRK D1 chart shows price action inside a bearish price channel.
It also shows price action between its descending 0.0% and 38.2% Fibonacci Retracement Fan levels.
The Bull Bear Power Indicator is bearish with a descending trendline.
The average bearish trading volumes are higher than the average bullish trading volumes.
MRK corrected as the S&P 500 Index rallied, a significant bearish confirmation.
My MRK Short Stock Trade
MRK Entry Level: Between $110.75 and $113.68
MRK Take Profit: Between $82.01 and $85.19
MRK Stop Loss: Between $120.25 and $124.00
Risk/Reward Ratio: 3.03